ProteoGenix - What is Proteomics?

Metabolomics

Metabolomics is the "systematic study of the unique chemical fingerprints that specific cellular processes leave behind" - specifically, the study of their small-molecule metabolite profiles. The metabolome represents the collection of all metabolites in a biological organism, which are the end products of its gene expression. Thus, while genomic and proteomic analyses do not tell the whole story of what might be happening in a cell, metabolic profiling can give an instantaneous 'snapshot' of the physiology of that cell. One of the challenges of systems biology is to integrate proteomics, transcriptomics, and metabolomics information to give a more complete picture of living organisms.

Source: Wikipedia

To Learn More About Metabolomics:

Metabolomics: The End Profile
Charles W. Schmidt, Environmental Health Perspectives, Volume 112, Number 7, May 2004, p. A 410

The Metabolomics Society

© Copyright 2005-2007. All rights reserved.

Proteogenix

Careers at ProteoGenix Director, Human Resources Director, Immunodiagnostics Product Development Research Associate, Immunodiagnostics Product Development

Management Board of Directors Research Staff

Intra-amniotic Infection Pre-term Birth Down Syndrome

Oregon Health & Science University Beckman Coulter Eli Lilly

Genomics Proteomics Metabolomics Bioinformatics

ProteoGenix Publishes Four Landmark Articles on Diagnostic Applications for Pregnancy (Journal of Proteome Research, April 2007) ProteoGenix Receives Best Clinical Study Award at SMFM Annual Meeting for Preterm Birth and Intra-amniotic Infection (February 2007) ProteoGenix Publishes Identification of Novel Biomarkers in Cervical-Vaginal Fluid for Noninvasive Detection of Intra-amniotic Infection (Journal of Proteome Research, January 2007) Test May Prevent Premature Births (BBC, July 2004) Discovery Could Help Prevent Premature Births (CNN and Associated Press, July 2004) Protein Linked to Premature Births (MSNBC and Associated Press, July 2004) OHSU test targets premature births: Scientists are developing a simple blood screening that could cut the number of risky early births nearly in half. (The Oregonian, July 2004) ProteoGenix Publishes Key Study of Intra-amniotic Infection (Journal of the American Medical Association, July 2004) ProteoGenix Scientists Describe Novel Mass Spec Algorithm (Analytical Chemistry, July 2004) ProteoGenix Receives NIH SBIR Award for "Diagnositic proteiomic profiles for aneuploidy" November 2003

Investor Information Contact Information